• 1
    Rollini P, Mach B, Gorski J. Linkage map of three HLA-DR beta-chain genes: evidence for a recent duplication event. Proc Natl Acad Sci U S A 1985; 82:7197201.
  • 2
    Chaplin DD. Overview of the immune response. J Allergy Clin Immunol 2010; 2(Suppl. 2):S323.
  • 3
    Sant AJ, Chaves FA, Krafcik FR, Lazarski CA, Menges P, Richards K, Weaver JM. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design. Expert Rev Vaccines 2007; 6:35768.
  • 4
    Sant AJ, Chaves FA, Jenks SA, Richards KA, Menges P, Weaver JM, Lazarski CA. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol Rev 2005; 207:26178.
  • 5
    Chen W, Anton LC, Bennink JR, Yewdell JW. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 2000; 12:8393.
  • 6
    Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999; 17:5188.
  • 7
    Kotturi MF, Scott I, Wolfe T et al. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 2008; 181:212433.
  • 8
    Liu F, Whitton JL, Slifka MK. The rapidity with which virus-specific CD8+ T cells initiate IFN-gamma synthesis increases markedly over the course of infection and correlates with immunodominance. J Immunol 2004; 173:45662.
  • 9
    Flesch IE, Woo WP, Wang Y, Panchanathan V, Wong YC, La Gruta NL, Cukalac T, Tscharke DC. Altered CD8+ T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F1 mice. J Immunol 2010; 184:4555.
  • 10
    Belz GT, Stevenson PG, Doherty PC. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8 T cell response to influenza A viruses. J Immunol 2000; 165:24049.
  • 11
    Day EB, Charlton KL, La Gruta NL, Doherty PC, Turner SJ. Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function. J Immunol 2011; 186:631928.
  • 12
    Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS. Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology 2007; 362:3149.
  • 13
    Moudgil KD, Wang J, Yeung VP, Sercarz EE. Heterogeneity of the T cell response to immunodominant determinants within hen eggwhite lysozyme of individual syngeneic hybrid F1 mice: implications for autoimmunity and infection. J Immunol 1998; 161:604653.
  • 14
    Sinha P, Snyder JA, Kim EY, Moudgil KD. The major histocompatibility complex haplotypes dictate and the background genes fine-tune the dominant versus the cryptic response profile of a T-cell determinant within a native antigen: relevance to disease susceptibility and vaccination. Scand J Immunol 2007; 65:15865.
  • 15
    Vukusic B, Poplonski L, Phillips L, Pawling J, Delovitch T, Hozumi N, Wither J. Both MHC and background gene heterozygosity alter T cell receptor repertoire selection in an antigen-specific response. Mol Immunol 1995; 32:135567.
  • 16
    Beck BN, Frelinger JG, Shigeta M, Infante AJ, Cummings D, Hammerling G, Fathman CG. T cell clones specific for hybrid I-A molecules. Discrimination with monoclonal anti-I-Ak antibodies. J Exp Med 1982; 156:118694.
  • 17
    Kimoto M, Fathman CG. Antigen-reactive T cell clones. II. Unique homozygous and (high responder × low responder)F1 hybrid antigen-presenting determinants detected using poly(Tyr, Glu)-poly D, L-Ala--poly Lys-reactive T cell clones. J Exp Med 1981; 153:37585.
  • 18
    Kimoto M, Fathman CG. Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation. J Exp Med 1980; 152:75970.
  • 19
    Matsunaga M, Seki K, Mineta T, Kimoto M. Antigen-reactive T cell clones restricted by mixed isotype A beta d/E alpha d class II molecules. J Exp Med 1990; 171:57782.
  • 20
    Lotteau V, Teyton L, Burroughs D, Charron D. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing. Nature 1987; 329:33941.
  • 21
    Lotteau V, Sands J, Teyton L, Turmel P, Charron D, Strominger JL. Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA. J Exp Med 1989; 169:3516.
  • 22
    Le Meur M, Waltzinger C, Gerlinger P, Benoist C, Mathis D. Restricted assembly of MHC class II molecules in transgenic mice. J Immunol 1989; 142:3237.
  • 23
    Germain RN, Bentley DM, Quill H. Influence of allelic polymorphism on the assembly and surface expression of class II MHC (Ia) molecules. Cell 1985; 43:23342.
  • 24
    Weaver JM, Sant AJ. Understanding the focused CD4 T cell response to antigen and pathogenic organisms. Immunol Res 2009; 45:12343.
  • 25
    Nanda NK, Sant AJ. DM determines the cryptic and immunodominant fate of T cell epitopes. J Exp Med 2000; 192:7818.
  • 26
    Menges PR, Jenks SA, Bikoff EK, Friedmann DR, Knowlden ZA, Sant AJ. An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice. J Immunol 2008; 180:161933.
  • 27
    Lazarski CA, Chaves FA, Sant AJ. The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability. J Exp Med 2006; 203:131928.
  • 28
    Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, Weaver JM, Sant AJ. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. Immunity 2005; 23:2940.
  • 29
    Gammon G, Shastri N, Cogswell J, Wilbur S, Sadegh-Nasseri S, Krzych U, Miller A, Sercarz E. The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol Rev 1987; 98:5373.
  • 30
    Deng H, Fosdick L, Sercarz E. The involvement of antigen processing in determinant selection by class II MHC and its relationship to immunodominance. APMIS 1993; 101:65562.
  • 31
    Richards KA, Chaves FA, Sant AJ. Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus. J Virol 2009; 83:656677.
  • 32
    Richards KA, Chaves FA, Krafcik FR, Topham DJ, Lazarski CA, Sant AJ. Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin. J Virol 2007; 81:760819.
  • 33
    Nayak JL, Richards KA, Chaves FA, Sant AJ. Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins. Viral Immunol 2010; 23:16980.
  • 34
    Akhoon BA, Slathia PS, Sharma P, Gupta SK, Verma V. In silico identification of novel protective VSG antigens expressed by Trypanosoma brucei and an effort for designing a highly immunogenic DNA vaccine using IL-12 as adjuvant. Microb Pathog 2011; 51:7787.
  • 35
    McNamara LA, He Y, Yang Z. Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis. BMC Immunol 2010; 11:18.
  • 36
    Fonseca SG, Coutinho-Silva A, Fonseca LA et al. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. AIDS 2006; 20:226373.
  • 37
    Fonseca CT, Cunha-Neto E, Goldberg AC et al. Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection. Clin Exp Immunol 2005; 142:53947.
  • 38
    Zhang GL, DeLuca DS, Keskin DB, Chitkushev L, Zlateva T, Lund O, Reinherz EL, Brusic V. MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J Immunol Methods 2011; 374:5361.
  • 39
    Kemp RA, Powell TJ, Dwyer DW, Dutton RW. Cutting edge: regulation of CD8+ T cell effector population size. J Immunol 2004; 173:29237.
  • 40
    Laouar Y, Crispe IN. Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo. Immunity 2000; 13:291301.
  • 41
    Gilfillan S, Aiso S, Smilek D, Woodland DL, Palmer E, McDevitt HO. An immune response defect due to low levels of class II cell surface expression. Analysis of antigen presentation and positive selection. J Immunol 1991; 147:407481.
  • 42
    Tourdot S, Gould KG. Competition between MHC class I alleles for cell surface expression alters CTL responses to influenza A virus. J Immunol 2002; 169:561521.
  • 43
    Suri A, Walters JJ, Kanagawa O, Gross ML, Unanue ER. Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: the lack of competition. Proc Natl Acad Sci U S A 2003; 100:53305.
  • 44
    Billam P, Bonaparte KL, Liu J et al. T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection. J Biol Chem 2011; 286:482941.
  • 45
    Martinic MM, Rocha B, McCoy KD, Hengartner H, Zinkernagel RM. Role of TCR-restricting MHC density and thymic environment on selection and survival of cells expressing low-affinity T cell receptors. Eur J Immunol 2004; 34:10419.
  • 46
    Watanabe N, Arase H, Onodera M, Ohashi PS, Saito T. The quantity of TCR signal determines positive selection and lineage commitment of T cells. J Immunol 2000; 165:625261.
  • 47
    Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, Jenkins MK. Naive CD4+ T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007; 27:20313.
  • 48
    Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol 2002; 76:58290.
  • 49
    Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 1995; 182:170315.